- Investing Ideas
- /
- Global Pharmaceuticals & Biotech Undervalued based on future growth
Global Pharmaceuticals & Biotech Undervalued based on future growth
Results
39
Companies which can be considered undervalued when accounting for expected future growth (PEG under 0.8)
39 companies
Grifols
Market Cap: €6.5b
Operates as a plasma therapeutic company in Spain, the United States, Canada, and internationally.
GRF
€10.66
7D
2.8%
1Y
-4.2%
PharmaEssentia
Market Cap: NT$177.7b
A biopharmaceutical company engages in treatment for human diseases in Taiwan and internationally.
6446
NT$480.50
7D
-4.1%
1Y
-9.8%
China Resources Pharmaceutical Group
Market Cap: HK$31.0b
An investment holding company, engages in the manufacture, distribution, and retail of pharmaceutical and other healthcare products in Mainland China and internationally.
3320
HK$4.93
7D
0.8%
1Y
-8.2%
ADMA Biologics
Market Cap: US$3.7b
A biopharmaceutical company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally.
ADMA
US$15.56
7D
7.2%
1Y
-18.3%
Hypera
Market Cap: R$16.2b
Operates as a pharmaceutical company in Brazil.
HYPE3
R$25.61
7D
3.1%
1Y
24.3%
Lotus Pharmaceutical
Market Cap: NT$77.3b
Engages in the research and development, manufacture, and sale of generic pharmaceutical products in Taiwan, South Korea, the United States, and internationally.
1795
NT$294.00
7D
5.4%
1Y
5.9%
Nanjing King-Friend Biochemical PharmaceuticalLtd
Market Cap: CN¥16.7b
Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd.
603707
CN¥10.36
7D
2.0%
1Y
-29.7%
Harmony Biosciences Holdings
Market Cap: US$2.0b
A commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients with rare and other neurological diseases in the United States.
HRMY
US$34.03
7D
8.3%
1Y
2.5%
Organon
Market Cap: US$2.0b
Develops and delivers health solutions through prescription therapies and medical devices in the United States, Europe, Canada, Japan, rest of the Asia Pacific, Latin America, the Middle East, Russia, Africa, and internationally.
OGN
US$7.53
7D
11.1%
1Y
-49.9%
Hugel
Market Cap: ₩2.6t
Develops and manufactures biopharmaceuticals in South Korea and internationally.
A145020
₩238,500.00
7D
11.4%
1Y
-13.6%
Alvotech
Market Cap: US$1.7b
Through its subsidiaries, develops and manufactures biosimilar medicines for patients worldwide.
ALVO
US$5.49
7D
-3.9%
1Y
-53.2%
Innoviva
Market Cap: US$1.7b
Engages in the development and commercialization of pharmaceutical products in the United States and internationally.
INVA
US$22.25
7D
6.7%
1Y
17.7%
Collegium Pharmaceutical
Market Cap: US$1.5b
A specialty pharmaceutical company, engages in the development and commercialization of medicines for pain management.
COLL
US$45.98
7D
8.7%
1Y
55.4%
Cosmo Pharmaceuticals
Market Cap: CHF 1.0b
Focuses on the development and commercialization products for gastroenterology, dermatology, and healthtech worldwide.
COPN
CHF 65.10
7D
4.3%
1Y
2.4%
Strides Pharma Science
Market Cap: ₹87.0b
Develops, manufactures, and sells pharmaceutical products in Africa, Australia, North America, Europe, Asia, and internationally.
STAR
₹943.55
7D
-0.5%
1Y
-33.3%
Genomma Lab Internacional. de
Market Cap: Mex$17.2b
Provides pharmaceutical and personal care products primarily in Mexico and internationally.
LAB B
Mex$17.59
7D
-1.3%
1Y
-33.9%
Ironwood Pharmaceuticals
Market Cap: US$510.8m
A biotechnology company, focuses on the development and commercialization of therapies for gastrointestinal (GI) and rare diseases in the United States and internationally.
IRWD
US$3.14
7D
63.5%
1Y
-25.4%
Zevra Therapeutics
Market Cap: US$499.9m
A commercial-stage company, focuses on addressing unmet needs for the treatment of rare diseases in the United States.
ZVRA
US$8.88
7D
0.8%
1Y
3.0%
Dong-A Socio Holdings
Market Cap: ₩691.8b
Engages in the pharmaceutical business in South Korea.
A000640
₩107,500.00
7D
1.7%
1Y
-4.5%
GlaxoSmithKline Pakistan
Market Cap: PK₨125.4b
Operates as a biopharma company in Pakistan.
GLAXO
PK₨393.75
7D
-1.2%
1Y
29.8%
SIGA Technologies
Market Cap: US$429.7m
A commercial-stage pharmaceutical company, focuses on the health security market in the United States.
SIGA
US$6.00
7D
-8.3%
1Y
1.0%
Newron Pharmaceuticals
Market Cap: CHF 301.8m
A biopharmaceutical company, discovers and develops novel therapies for patients with diseases of the central and peripheral nervous system in Italy and the United States.
NWRN
CHF 15.12
7D
6.5%
1Y
107.1%
Beximco Pharmaceuticals
Market Cap: ৳46.0b
Manufactures and markets generic pharmaceutical formulations and active pharmaceutical ingredients in Bangladesh.
BXPHARMA
৳103.20
7D
-7.1%
1Y
12.9%
Clinuvel Pharmaceuticals
Market Cap: AU$556.2m
A biopharmaceutical company, focuses on developing and commercializing treatments for patients with genetic, metabolic, systemic, and life-threatening disorders in Australia, Europe, the United States, Switzerland, and internationally.
CUV
AU$11.08
7D
2.9%
1Y
-16.6%
Essex Bio-Technology
Market Cap: HK$2.5b
An investment holding company, develops, manufactures, and sells biologic drugs in China, Hong Kong, and internationally.
1061
HK$4.47
7D
1.1%
1Y
70.0%
JBM (Healthcare)
Market Cap: HK$2.3b
An investment holding company, engages in the manufacture, marketing, distribution, and sale of branded healthcare and wellness products in Hong Kong, Macau, Mainland China, and internationally.
2161
HK$2.85
7D
-0.3%
1Y
120.9%
Egyptian International Pharmaceutical Industries
Market Cap: ج.م12.9b
Manufactures and sells pharmaceutical ampoules in Egypt and internationally.
PHAR
ج.م76.20
7D
-2.6%
1Y
58.3%
Abeona Therapeutics
Market Cap: US$241.2m
A clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases.
ABEO
US$4.45
7D
6.0%
1Y
-24.1%
Chong Kun Dang Holdings
Market Cap: ₩230.6b
Manufactures and distributes pharmaceutical products in South Korea and internationally.
A001630
₩48,450.00
7D
7.5%
1Y
-4.6%
Protalix BioTherapeutics
Market Cap: US$149.6m
A biopharmaceutical company, engages in the development, production, and commercialization of recombinant therapeutic proteins based on the ProCellEx plant cell-based protein expression system.
PLX
US$1.86
7D
-15.1%
1Y
32.9%
Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) (S.A.E)
Market Cap: ج.م6.3b
Produces and sells a range of branded generic pharmaceuticals, food supplements, veterinary products, and nutraceuticals in Egypt.
RMDA
ج.م4.16
7D
-1.4%
1Y
16.9%
Atara Biotherapeutics
Market Cap: US$96.6m
Engages in the development of transformative therapies for patients with cancer and autoimmune disease in the United States and the United Kingdom.
ATRA
US$13.76
7D
16.5%
1Y
14.7%
Hyphens Pharma International
Market Cap: S$108.1m
Operates as a specialty pharmaceutical and consumer healthcare company primarily in Singapore, Vietnam, Malaysia, and internationally.
1J5
S$0.35
7D
-2.8%
1Y
25.0%
EZZ Life Science Holdings
Market Cap: AU$115.1m
Engages in formulation, production, marketing, and sale of the health and wellbeing products in Australia, New Zealand, Mainland China, and South-East Asia.
EZZ
AU$2.44
7D
0.8%
1Y
-17.3%
hVIVO
Market Cap: UK£43.2m
Operates as a pharmaceutical service and contract research company in the United Kingdom, Europe, and North America.
HVO
UK£0.064
7D
-0.8%
1Y
-75.8%
Decibel Cannabis
Market Cap: CA$75.0m
An integrated cannabis company, engages in the cannabis cultivation in Canada.
DB
CA$0.13
7D
0%
1Y
100.0%